ReviewInternational journal of pediatrics2013
Kawasaki Disease: A Clinician's Update.
Review in International journal of pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 70 citations in OpenAlex.
- Atypical Kawasaki Disease in a 5-month-old Infant.Annals of African medicine · 2025Article
- Article
- Comparison of IVIG resistance predictive models in Kawasaki disease.Pediatric research · 2022Article
- Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.Vaccines · 2021Article
- Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease.Immunity, inflammation and disease · 2021Article
- Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.Medicine · 2020Observational
- The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.BioMed research international · 2020Article
- A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.Rheumatology international · 2019Observational
- Kawasaki disease among Egyptian children: A case series.Global cardiology science & practice · 2017Article
- Kawasaki disease: a matter of innate immunity.Clinical and experimental immunology · 2016Review
- Two infants with tuberculid associated with Kawasaki disease.Human vaccines & immunotherapeutics · 2016Article
- Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease.Iranian journal of pediatrics · 2016Article
- Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?Clinical rheumatology · 2016Article
- Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study.Korean circulation journal · 2016Article
- Vitamin D nutritional status and the risk for cardiovascular disease.Experimental and therapeutic medicine · 2016Article
- Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.BMJ case reports · 2016Article
- Profiles of responses of immunological factors to different subtypes of Kawasaki disease.BMC musculoskeletal disorders · 2015Article
- Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.Pediatric cardiology · 2015Article
- Does Vitamin C improve endothelial function in patients with Kawasaki disease?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2015Article
- Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.The British journal of general practice : the journal of the Royal College of General Practitioners · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims. Kawasaki disease is an acute systemic vasculitis and is the most common cause of acquired heart disease in children in the developed world. This review aims to synthesise recent insights into the disease and provide an update for clinicians on diagnostic and treatment practices. Methods. We conducted a review of the literature exploring epidemiology, aetiology, diagnosis, and management of Kawasaki disease. We searched MEDLINE, Medline In-Process, Embase, Google Scholar, and reference lists of relevant articles. Conclusions. Kawasaki disease is a febrile vasculitis which progresses to coronary artery abnormalities in 25% of untreated patients. The disease is believed to result from a genetically susceptible individual's exposure to an environmental trigger. Incidence is rising worldwide, and varies widely across countries and within different ethnic groups. Diagnosis is based on the presence of fever in addition to four out of five other clinical criteria, but it is complicated by the quarter of the Kawasaki disease patients with "incomplete" presentation. Treatment with intravenous immunoglobulin within ten days of fever onset improves clinical outcomes and reduces the incidence of coronary artery dilation to less than 5%. Given its severe morbidity and potential mortality, Kawasaki disease should be considered as a potential diagnosis in cases of prolonged paediatric fever.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.